Export this Data | Chart Risk Level by Product Clear Chart
Add More Filters: Risk_level, Use_site, Surface_type, Formulation_type, Why_on_List_N,
Active_ingredient (array) ✖
ID ▼ | EPA_reg_num | Risk_level | Active_ingredient | Product_name | Company | Use_site | Surface_type | Contact_time | Formulation_type | Follow_directions_for_this_virus | Date_on_List_N | Why_on_List_N |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1027 | 9480-11 | Increased Risk | Quaternary ammonium | BackSpray RTU | Professional Disposables International Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2020-11-19 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1029 | 92378-2 | Increased Risk | Quaternary ammonium | Atmosphere | Atmosphere Global LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-09-28 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1041 | 10324-85 | Increased Risk | Quaternary ammonium | Maquat 86-M | Mason Chemical Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2020-10-29 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1042 | 4091-21 | Increased Risk | Quaternary ammonium | Condor 2 | W.M. Barr & Company Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN); Residual | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2020-10-29 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1053 | 4091-20 | Increased Risk | Quaternary ammonium | Phoenix 2 | W.M. Barr & Company Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2020-10-21 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1056 | 1839-166 | Increased Risk | Quaternary ammonium | BTC 885 NDC-128 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-15 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1067 | 1839-167 | Increased Risk | Quaternary ammonium | BTC 885 Neutral Disinfectant Cleaner-256 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1068 | 1839-169 | Increased Risk | Quaternary ammonium | BTC 885 Neutral Disinfectant Cleaner-64 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1069 | 1839-168 | Increased Risk | Quaternary ammonium | BTC 885 NDC-32 | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1070 | 1839-176 | Increased Risk | Quaternary ammonium | Liquid-pak Neutral Disinfectant Cleaner | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-10-08 | Tested against SARS-CoV-2 (COVID-19) |
1099 | 6836-136 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1100 | 6836-140 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1101 | 6836-152 | Increased Risk | Quaternary ammonium | Lonza Formulation DC-103 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1102 | 6836-77 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1103 | 6836-381 | Increased Risk | Quaternary ammonium | Lonzagard R-82G | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1104 | 6836-139 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1105 | 6836-346 | Increased Risk | Quaternary ammonium | Lonzagard RCS-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1106 | 6836-347 | Increased Risk | Quaternary ammonium | Lonzagard RCS-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1107 | 6836-348 | Increased Risk | Quaternary ammonium | Lonzagard RCS-128 PLUS | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1108 | 6836-349 | Increased Risk | Quaternary ammonium | Lonzagard RCS-256 Plus | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1109 | 6836-75 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1110 | 6836-78 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1135 | 9480-4 | Increased Risk | Quaternary ammonium; Isopropanol (Isopropyl alcohol) | Super Sani-Cloth Germicidal Disposable Wipe | Professional Disposables International Inc | Healthcare; Institutional | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Wipe | SARS-CoV-2 | 2020-09-24 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1145 | 1839-83 | Increased Risk | Quaternary ammonium | Detergent Disinfectant Pump Spray | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2020-09-10 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1185 | 1839-100 | Increased Risk | Quaternary ammonium | Veterinarian Type Disinfectant | Stepan Company | Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1190 | 70144-4 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Opti-cide Max Wipes | Micro-Scientific LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Wipe | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1197 | 89833-3 | Increased Risk | Quaternary ammonium | D7 Part 1 | Decon7 Systems LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-20 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1205 | 1839-80 | Increased Risk | Quaternary ammonium | NP 12.5 Detergent/Disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19) |
1206 | 1839-97 | Increased Risk | Quaternary ammonium | NP 12.5 (D&F) Detergent/Disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-26 | Tested against SARS-CoV-2 (COVID-19) |
1223 | 88494-2 | Increased Risk | Ethanol (Ethyl alcohol); Quaternary ammonium | Wedge Disinfectant Wipes | North American Infection Control Ltd | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Wipe | Mycobacterium bovis | 2020-03-26 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19) |
1263 | 10492-4 | Increased Risk | Quaternary ammonium; Isopropanol (Isopropyl alcohol) | Discide Ultra Disinfecting Towelettes | Palmero Healthcare LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Wipe | Adenovirus Type 2 | 2020-06-11 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1270 | 71355-1 | Increased Risk | Quaternary ammonium; Glutaraldehyde | Virocid | CID Lines NV | Institutional | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-10-26 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1298 | 6836-372 | Increased Risk | Quaternary ammonium | Nugen 2m Disinfectant Wipes | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Wipe | SARS-CoV-2 | 2020-05-07 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1335 | 88897-1 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol); Isopropanol (Isopropyl alcohol) | Panther Disinfectant Towelette | Maxill Inc | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Wipe | SARS-CoV-2 | 2021-10-26 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1345 | 1839-96 | Increased Risk | Quaternary ammonium | NP 9.0 (D&F) Detergent/disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-04-23 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1354 | 70144-5 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Opti-cide Max | Micro-Scientific LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-06-01 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1400 | 1839-81 | Increased Risk | Quaternary ammonium | NP 9.0 Detergent/disinfectant | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2020-03-13 | Tested against SARS-CoV-2 (COVID-19) |
1423 | 46781-12 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol); Isopropanol (Isopropyl alcohol) | Cavicide 1 | Metrex Research | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-02-11 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1424 | 46781-13 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol); Isopropanol (Isopropyl alcohol) | Caviwipes 1 | Metrex Research | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Wipe | SARS-CoV-2 | 2021-01-07 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1440 | 6836-362 | Increased Risk | Quaternary ammonium | Nugen MB5A-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1441 | 6836-363 | Increased Risk | Quaternary ammonium | Nugen MB5A-64 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1442 | 6836-366 | Increased Risk | Quaternary ammonium | Nugen MB5N-64 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1459 | 47371-129 | Increased Risk | Quaternary ammonium | Formulation HWS- 256 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1460 | 47371-130 | Increased Risk | Quaternary ammonium | Formulation HWS-128 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1461 | 47371-131 | Increased Risk | Quaternary ammonium | HWS-64 | H&S Chemicals Division of Arxada LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1462 | 47371-192 | Increased Risk | Quaternary ammonium | Formulation HWS-32 | H&S Chemicals Division of Arxada LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1483 | 6836-361 | Increased Risk | Quaternary ammonium | Nugen MB5A-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1484 | 6836-364 | Increased Risk | Quaternary ammonium | Nugen MB5N-256 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1485 | 6836-365 | Increased Risk | Quaternary ammonium | Nugen MB5N-128 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1501 | 88494-3 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Peak Disinfectant | North American Infection Control Ltd | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | Poliovirus Type 1; Rhinovirus | 2020-03-03 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1503 | 9480-10 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol); Isopropanol (Isopropyl alcohol) | Sani-Prime Germicidal Spray | Professional Disposables International Inc | Healthcare; Institutional | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-03-02 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1530 | 88494-1 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Wedge Disinfectant | North American Infection Control LTD | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | Human coronavirus | 2020-03-13 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
1580 | 96706-1 | Increased Risk | Quaternary ammonium; Isopropanol (Isopropyl alcohol) | MBS MedTech Germicidal* Disposable Wipes | Medical Biowaste Solutions Inc | Healthcare; Institutional | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Wipe | SARS-CoV-2 | 2021-05-25 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1720 | 9480-13 | Increased Risk | Quaternary ammonium | Backspin No-Rinse FCSS | Professional Disposables International Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact No Rinse (FCNR) | 1.0 minutes | Wipe | SARS-CoV-2 | 2021-03-09 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1742 | 66243-2 | Increased Risk | Quaternary ammonium | Odo-Ban | Clean Control Corp | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Dilutable | Human coronavirus | 2021-03-16 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
1743 | 66243-1 | Increased Risk | Quaternary ammonium | Odo-Ban Ready-To-Use | Clean Control Corp | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | Human coronavirus | 2021-03-16 | Kills a human coronavirus similar SARS-CoV-2 (COVID-19) |
2040 | 4091-26 | Increased Risk | Quaternary ammonium | Emu | W.M. Barr & Company Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-06-08 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2229 | 6836-138 | Increased Risk | Quaternary ammonium | Lonza Formulation S-38-F | Arxada, LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-11-23 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2230 | 6836-73 | Increased Risk | Quaternary ammonium | Lonza Formulation S-38 | Arxada, LLC | Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-11-23 | Tested against SARS-CoV-2 (COVID-19) |
2364 | 1839-259 | Increased Risk | Quaternary ammonium | BTC 885 NDC RTU | Stepan Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2022-06-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2368 | 46781-19 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | QHA-45-W | Metrex Research | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Wipe | SARS-CoV-2 | 2022-06-27 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2408 | 70627-84 | Increased Risk | Quaternary ammonium | Virex Plus | Diversey, Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2409 | 10324-194 | Increased Risk | Quaternary ammonium | Maquat 2420-10 | Mason Chemical Company | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19) |
2412 | 63838-36 | Increased Risk | Quaternary ammonium | EP-Q7.5 | Enviro Tech Chemical Services, Inc. | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2022-08-31 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2581 | 1130-20 | Increased Risk | Quaternary ammonium | Disinfectant I | Weiman Products, LLS | Hospital; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2023-04-28 | Tested against SARS-CoV-2 (COVID-19) |
2600 | 9480-12 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol); Isopropanol (Isopropyl alcohol) | Sani-Cloth Prime Germicidal Disposable Wipe | Professional Disposables International Inc | Healthcare | Hard Nonporous (HN) | 1.0 minutes | Wipe | Feline calicivirus | 2023-06-06 | Kills a harder-to-kill pathogen than SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
2623 | 100098-1 | Increased Risk | Quaternary ammonium; Hydrogen peroxide | Zoono Z-91 Microbe Shield | Zoono Holdings USA | Hospital; Institutional, Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2023-08-02 | Tested against SARS-CoV-2 (COVID-19) |
Safer Disinfectants is a project of the Maryland Pesticide Education Network
© 2021. All rights reserved.